MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciaf212

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026

Performance of a Novel Plasmodium falciparum Rapid Diagnostic Test in Areas of Widespread hrp2/3 Gene Deletion.

Mandefro Aynalem, Ding Xavier C, Farge Jocelyn, Alemayehu Gezahegn Solomon, Tadele Geletta, Mekonen Bacha, Gebrehiwot Yirgalem, Berhe Nega, Erko Berhanu, Slater Hannah C, Bizilj Greg T, Barney Rebecca, Golden Allison, Domingo Gonzalo J, Golassa Lemu

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Rapid diagnostic tests (RDTs) have improved malaria diagnosis; however, the emergence of hrp2/3 gene deletions threatens the reliability of HRP2-based RDTs. This study evaluated the diagnostic performance of a novel RDT detecting both HRP2 and PfLDH in a single test line.

METHOD: A cross-sectional study was conducted at two health centers in Ethiopia, recruiting 1004 study participants. Blood samples were tested using the novel and comparator RDTs, using microscopy and nested polymerase chain reaction (PCR) as the reference standards. Plasmodium falciparum hrp2 and hrp3 genotyping and HRP2 and P. falciparum lactate dehydrogenase (PfLDH) antigen quantification were also conducted.

RESULTS

In this study setting, characterized by 80% of P. falciparum infections showing hrp2 or hrp3 deletion, the novel RDT showed a sensitivity of 77.4% and a specificity of 96%, surpassing the HRP2-only comparators Bioline™ Malaria Ag Pf (55.9%) and Bioline™ Malaria Ag Pf/Pv (56.8%). Its performance was comparable to the three-line Bioline™ Malaria Ag Pf/Pf/Pv RDT, which detects HRP2, PfLDH, and PvLDH, at 77.7% sensitivity. Additionally, the novel RDT exhibited the ability to detect P. falciparum cases across a broader range of HRP2 and PfLDH antigen concentrations compared to the comparator RDTs.

CONCLUSIONS

The single-line, easy-to-interpret index malaria RDT outperforms conventional HRP2-only RDTs, making it a promising tool for enhancing malaria diagnosis in regions with high hrp2/3 deletion prevalence. Clinical Trial Registration.  The study is registered on ClinicalTrials.gov ID NCT05286359.

Для цитирования: Mandefro Aynalem, Ding Xavier C, Farge Jocelyn, Alemayehu Gezahegn Solomon, Tadele Geletta, Mekonen Bacha, Gebrehiwot Yirgalem, Berhe Nega, Erko Berhanu, Slater Hannah C, Bizilj Greg T, Barney Rebecca, Golden Allison, Domingo Gonzalo J, Golassa Lemu. Performance of a Novel Plasmodium falciparum Rapid Diagnostic Test in Areas of Widespread hrp2/3 Gene Deletion.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2026. DOI: 10.1093/cid/ciaf212.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.